top of page
Longitudinal Real‑World Evidence Registry
Expansion of an oncology research registry
Context
An oncology registry originally developed within a clinical network in Minnesota expanded following updated IRB approval to support oncology participants across multiple sites in the United States and enable longitudinal monitoring of treatment experience and patient outcomes.
Deployment
- Digital patient enrolment and consent
- Structured patient‑reported outcome reporting
- Treatment and symptom tracking
- Centralised data aggregation for research analysis
Signals
The expanded registry supports observational oncology research by enabling structured longitudinal monitoring of treatment experience, symptom progression and patient outcomes across diverse care settings.
COMPLETED PROGRAM
IRB‑approved expansion | multi‑site oncology participation | longitudinal patient outcome monitoring
bottom of page